Copy
View this email in your browser

July 2020

8th IPCRG Clinical Practice Webinar & Abstract Presentations

COVID-19 & the Importance of Public Information and Education in Primary Care 

Presenters: Sundeep Salvi, India & Javiera Corbalán, Chile 


  Saturday 4 July 2020, 1500-1700hrs BST

On Saturday 4 July we will hold the final webinar in the current IPCRG series. This webinar will cover the very topical area of COVID-19 & the Importance of Public Information and Education in Primary Care and we are delighted to welcome two IPCRG colleagues, Sundeep Salvi from India & Javiera Corbalán from Chile, who will share their experiences.  
Sundeep trained as a Pulmonologist and is the Director of Pulmocare Research and Education Foundation (PURE), based in Pune.
Javiera is a family doctor and works in a Paediatric Emergency Department and at the Universidad Austral de Chile. 
Both our presenters are speaking from countries tackling significant COVID-19 problems and we are grateful to them for taking the time to share their knowledge and experience with the IPCRG community.  They will each present their country’s perspective on the main public information/education challenges for primary care and public health including: managing misinformation; role of social media; political versus health decisions; best practices; and recommendations for primary care when dealing with individual patients and populations.  Between them, they will give an update on key topics such as public information on symptoms, physical distancing, hand washing and masks. We invite attendees to share their experiences, evidence and questions.
These presentations will be followed by six of the most highly ranked abstracts previously selected for presentation at 10th IPCRG World Conference, due to have been held in Dublin earlier this year. These webinars are enabling researchers to share their work with you, an international audience, whilst gaining important peer review that otherwise might have been missed during the current pandemic.
 
So please join us by registering at: https://www.ipcrg.org/conferences/ipcrg-2020-virtual-conference-sessions
Programme, Saturday 4 July 2020
 
Timing BST
Welcome Janwillem Kocks, President-Elect IPCRG 1500-1505
Plenary Session 1 COVID-19 & the Importance of Public Information and Education in Primary Care: The Indian experience, and an update on physical distancing, handwashing and masks 
Presenter: Sundeep Salvi, India.
1505-1520
Plenary Session 2 COVID-19 & the Importance of Public Information and Education in Primary Care: The Chilean experience, and an update on information about symptoms and testing
Presenter: Javiera Corbalán, Chile.
1520-1535
  Discussion with Q&A 1535-1550
Video & Comfort Break
Oral Abstracts
  1. Ademgenoot – A serious game to motivate and empower asthma patients in adherence to their maintenance medication: A user-centered design study Charlotte Poot, The Netherlands 
1600-1610
 
  1. Virtual Home-Based Pulmonary Rehabilitation Programme for COPD Patients Cathy Gillen, Ireland
1610-1620
 
  1. Prevalence of vitamin D deficiency and insufficiency in patients with chronic obstructive pulmonary disease Malek Chaabouni, Tunisia
1620-1630
 
  1. Chronic respiratory disease (CRD) surveys in low- and middle-income countries (LMICs): A systematic scoping review of methodologies and outcomes Nik Sherina Hanafi, Malaysia
1630-1640
 
  1. Development and validation of reference equations for lung function in healthy Sri Lankan Tamils Mathanki Sooriyakanthan, Sri Lanka
1640-1650
 
  1. Assessing feasibility of methods to estimate cost of illness of COPD in western rural India Ankita Shrivastava, India
1650-1700
Close Janwillem Kocks, President-Elect IPCRG 1700-1705
All resources from previous IPCRG webinars, including the presentations and session recordings, can be found by following the links below:
16 May COVID-19 in Primary Care: Supporting those Suffering & Recovering Presenters: Steve Holmes, UK & Matthieu Bremond, France
23 May COVID-19 in Primary Care: Supporting People’s Mental Health Presenters: Lindsay Ip, UK & Jaime Correia de Sousa, Portugal
30 May COVID-19 in Primary Care: Protecting the Most Vulnerable Presenters: Hanna Sandelowsky, Sweden & Chunhua Chi, China
6 June COVID-19 & the Primary Care Management of Asthma Presenters: Dermot Nolan, Ireland & Alan Kaplan, Canada
13 June COVID-19 & the Challenges of Diagnosing Asthma in Primary Care Presenters: Luke Daines, UK & Jim Stout, USA
20 June COVID-19 & Diagnosis and Management of COPD in Primary Care Presenters: Hilary Pinnock & Vince Mak, UK
27 June The Impact of Nicotine & Smoking in COVID-19 & Chronic Respiratory Diseases (Asthma & COPD):  A Conversation & Case Study Discussion Presenters: Noel Baxter & Darush Attar-Zadeh, UK
IPCRG also has frequently updated resources on many aspects of COVID-19. These can be accessed by following this link: https://www.ipcrg.org/news/covid-19-open-source-sources-of-information. There are a wide variety of resources including:
  • Expert Recommendations for the Prevention and Control of COVID-19 Infections in Primary Care (First Edition)
  • Handbook on COVID-19 Infection, Prevention and Control in Communities: Compiled and published by the Bureau of Disease Prevention and Control of National Health Commission of People’s Republic of China
IPCRG would like to express their appreciation to Astra Zeneca for supporting this, and three of the other webinars, during this series.
Respiratory & Immunology is one of AstraZeneca’s three therapy areas and is a key growth driver for the Company.

AstraZeneca is an established leader in respiratory care, and its inhaled and biologic medicines reached more than 53 million patients in 2019. Building on a 50-year heritage, the Company aims to transform the treatment of asthma and COPD by focusing on earlier biology-led treatment, eliminating preventable asthma attacks, and removing COPD as a top-three leading cause of death. The Company’s early respiratory research is focused on emerging science involving immune mechanisms, lung damage and abnormal cell repair processes in disease and neuronal dysfunction.

With common pathways and underlying disease drivers across respiratory and immunology, AstraZeneca is following the science from chronic lung diseases to immunology-driven disease areas. The Company’s growing presence in immunology is focused on five mid- to late-stage franchises with multi-disease potential, in areas including rheumatology (including lupus), dermatology, gastroenterology, and systemic eosinophilic-driven diseases. AstraZeneca’s ambition in Respiratory & Immunology is to achieve disease modification and durable remission for millions of patients worldwide.
Go to www.ipcrg.org to find out more about the IPCRG, a charity  working locally in primary care and collaborating globally to improve respiratory health so that we can achieve our vision of a global population breathing and feeling well through universal access to right care.
 
We look forward to seeing you at the webinar on Saturday 4 July and on behalf of us all at IPCRG, we would like to thank you for supporting us over the past two months.
 
Keep well, stay safe.
 
Ioanna Tsiligianni               
President IPCRG             

Siân Williams
CEO IPCRG
The International Primary Care Respiratory Group (IPCRG) is a charity registered in Scotland working internationally (SC No: 035056) and a company limited by guarantee (Company number 256268)
 
The IPCRG is the Respiratory Special Interest Group of WONCA Europe and an Organisation in Collaborative Relations with WONCA Global 


The IPCRG is the primary care representative on WHO-Global Alliance against Chronic Respiratory Diseases (GARD) Planning Executive


Supporter of the NCD Alliance
 
www.ipcrg.org
Twitter
Facebook
Website
Copyright © 2020 IPCRG, All rights reserved.


Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.